Mayo Clinic, Minnesota
Patrick M. Wieruszewski, PharmD, BCCCP, FCCM is a clinical pharmacist and appointed Associate in the cardiothoracic surgery ICU and ECMO program at Mayo Clinic and serves as Chairman for Clinical Pharmacy Research at Mayo Clinic. He has dual academic appointment as Assistant Professor in the fields of Anesthesiology and Pharmacy in the Mayo Clinic College of Medicine. His research focuses on the understanding of human circulatory physiology, hemodynamic dysregulation, and vascular dysfunction.
Thromboembolic Events in the Angiotensin II for the Treatment of High-Output Shock Phase 3 Trial
Sunday, March 22, 2026
9:45 AM - 10:45 AM Central Time
Disclosure information not submitted.
Effect of Cystatin C on Initial Bivalirudin Dose Selection in Acutely Ill Patients
Monday, March 23, 2026
9:00 AM - 10:00 AM Central Time
Disclosure information not submitted.
Monday, March 23, 2026
9:50 AM - 10:05 AM Central Time
Disclosure(s): Viatris: Consultant (Terminated, March 19, 2024); Wolters-Kluwer UpToDate: Consultant (Ongoing)
Activated Factor VII Use for Refractory Hemorrhage on ECMO
Monday, March 23, 2026
2:30 PM - 3:30 PM Central Time
Disclosure information not submitted.
Effect of Steroids on Cystatin C and Estimated Glomerular Filtration Rate in Hospitalized Patients
Tuesday, March 24, 2026
10:00 AM - 11:00 AM Central Time
Disclosure information not submitted.
Clinical Outcomes of Routine Antithrombin Supplementation During Extracorporeal Membrane Oxygenation
Tuesday, March 24, 2026
11:15 AM - 12:15 PM Central Time
Disclosure information not submitted.
